Cargando…

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease

BACKGROUND: Urate and homocysteine are potential biomarkers for disease progression in Parkinson’s disease (PD). Baseline serum urate concentration has been shown to predict motor but not cognitive decline. The relationship between serum homocysteine concentration and cognitive and motor impairment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sleeman, Isobel, Lawson, Rachael A., Yarnall, Alison J., Duncan, Gordon W., Johnston, Fionnuala, Khoo, Tien K., Burn, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2019
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597987/ https://www.ncbi.nlm.nih.gov/pubmed/30909247 http://dx.doi.org/10.3233/JPD-181535

Ejemplares similares

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease
por: Dissanayaka, Nadeeka N.W., et al.
Publicado: (2017)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2017)

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Mak, Elijah, et al.
Publicado: (2015)

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson’s Disease
por: Morris, Rosie, et al.
Publicado: (2017)

Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
por: Lawson, Rachael A., et al.
Publicado: (2014)

Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Nombela, Cristina, et al.
Publicado: (2014)

Cognitive impairment in Parkinson's disease: impact on quality of life of carers
por: Lawson, RA, et al.
Publicado: (2016)

Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease
por: Durcan, R., et al.
Publicado: (2019)

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
por: Lawson, Rachael A., et al.
Publicado: (2016)

Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort
por: Lawson, Rachael A., et al.
Publicado: (2021)

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)
por: Williams‐Gray, Caroline H., et al.
Publicado: (2016)

Identifying delirium in Parkinson disease: A pilot study
por: Lawson, Rachael A., et al.
Publicado: (2020)

Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
por: Wilson, Joanna, et al.
Publicado: (2020)

Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease
por: Mak, Elijah, et al.
Publicado: (2017)

Factors Influencing Habitual Physical Activity in Parkinson’s Disease: Considering the Psychosocial State and Wellbeing of People with Parkinson’s and Their Carers
por: Mc Ardle, Ríona, et al.
Publicado: (2022)

Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease
por: Ray, Nicola J, et al.
Publicado: (2022)

Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology
por: Wilson, Joanna, et al.
Publicado: (2020)

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)
por: Dlay, J. K., et al.
Publicado: (2020)

Serum homocysteine level in newly diagnosed young patients with abnormal glucose tolerance
por: Rijal, Amrit, et al.
Publicado: (2023)

Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease
por: Carbutt, Sophia, et al.
Publicado: (2015)

Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease
por: Pyle, Angela, et al.
Publicado: (2016)

Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease
por: Lord, Sue, et al.
Publicado: (2014)

Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD
por: Naisby, J., et al.
Publicado: (2021)

Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination
por: Li, Juan, et al.
Publicado: (2022)

Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study
por: Martin-Ruiz, Carmen, et al.
Publicado: (2020)

Natural history of falls in an incident cohort of Parkinson’s disease: early evolution, risk and protective features
por: Lord, Sue, et al.
Publicado: (2017)

Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease
por: Sigurdsson, Hilmar P., et al.
Publicado: (2022)

Does Serum Urate Change as Parkinson’s Disease Progresses?
por: Hasimoglu, Yasemin G., et al.
Publicado: (2020)

Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead
por: Del Din, Silvia, et al.
Publicado: (2021)

Preliminary Consequences of Blood Pressure Management and Blood Homocysteine Levels with Perindopril in Newly Diagnosed Hypertensive Patients in the Vietnamese Population
por: Kim Tran, Son, et al.
Publicado: (2023)

Initial Medication in Patients of Newly Diagnosed Parkinson’s Disease in Taiwan
por: Guo, Yi-Jen, et al.
Publicado: (2014)

Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson’s Disease
por: Wang, Juan, et al.
Publicado: (2016)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective?
por: Kocer, Bilge, et al.
Publicado: (2016)

Role of homocysteine in the development and progression of Parkinson’s disease
por: Fan, Xiaoyan, et al.
Publicado: (2020)

Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study
por: Hou, Yanbing, et al.
Publicado: (2022)

The Impact of Physical Activity on Non-Motor Symptoms in Parkinson’s Disease: A Systematic Review
por: Cusso, Melanie E., et al.
Publicado: (2016)

Dose-response meta-analysis on urate, gout, and the risk for Parkinson’s disease
por: Chang, Hongtao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pra58uvpmvv1mvtivah09ncpu7